OakChart

Mirion Technologies Inc

MIRIndustrials·Specialty Industrial Machinery·USA·Mid·NYSE·Nov 11 • 3:59 PM ET

17.70-1.56 (-8.10%)
2026-11-11 23:25 CET
Market cap
4,728.20 USD m
Revenue, TTM
1,079.60 USD m
Net income, TTM
29.00 USD m
Free cash flow, TTM
171.10 USD m
EPS diluted, TTM
0.10
P/E
170.19
Compare

Price

MIR against its 20, 50 and 200-day averages
2050200beatmiss
14.0016.0018.0020.0022.005.5M11.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MIRclose 17.7020-day 16.8750-day 16.24200-day 17.9817.7052w low

36.8% under the 52-week high of 28.00 on 12 Nov 2025. 52-week low 14.04 on 1 Oct 2026. Last 15 sessions, 35.6% high to low

Volume 2.21× normal · the line is the 50-bar volume average

Profile

MIR
52-week range, 26% of the way up
14.0428.00

Mirion Technologies, Inc. engages in the provision of radiation safety, science, and medicine. It operates through the Nuclear and Safety, and Technologies segments. The Nuclear and Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense. The Technologies segment involves nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. The company was founded by Thomas D. Logan in December 2005 and is headquartered in Atlanta, GA.

IndexRUT
Employees3281
IPOAug 20, 2020
Beta1.06
ATR, 14d1.05
Rel volume2.21
Short float15.46%
Insider own5.84%
Inst own107.94%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap4.35B
Enterprise Value5.22B
Income29.00M
Sales1.08B
Book/sh7.27
Cash/sh1.71
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees3281
IPOAug 20, 2020

Ratios

P/E170.19
Forward P/E27.02
PEG1.42
P/S4.02
P/B2.43
P/C10.37
P/FCF25.40
EV/EBITDA22.41
EV/Sales4.83
Quick Ratio2.49
Current Ratio3.02
Debt/Eq0.70
LT Debt/Eq0.69
Option/ShortYes / Yes

Earnings

EPS (ttm)0.10
EPS next Y0.66
EPS next Q0.21
EPS this Y17.50%
EPS next Y21.19%
EPS next 5Y18.99%
EPS past 3/5Y- -
Sales past 3/5Y8.84% -
EPS Y/Y TTM-2.62%
Sales Y/Y TTM19.65%
EPS Q/Q139.82%
Sales Q/Q24.52%
EarningsOct 27 AMC
EPS/Sales Surpr.-0.66% 0.89%

Ownership

Insider Own5.84%
Insider Trans0.14%
Inst Own107.94%
Inst Trans-1.58%
ROA0.83%
ROE1.60%
ROIC0.96%
Gross Margin38.72%
Oper. Margin7.36%
Profit Margin2.69%
SMA204.94%
SMA508.99%
SMA200-1.53%
Trades-

Technical

Shs Outstand239.73M
Shs Float231.16M
Short Float15.46%
Short Ratio8.67
Short Interest35.74M
52W High28.00 -36.79%
52W Low14.04 26.07%
Volatility7.24% 5.52%
ATR (14)1.05
RSI (14)53.74
Beta1.06
Rel Volume2.21
Avg Volume4.12M
Volume9,130,757

Performance

Perf Week-1.50%
Perf Month7.80%
Perf Quarter13.46%
Perf Half Y-5.04%
Perf YTD-24.42%
Perf Year-34.03%
Perf 3Y117.44%
Perf 5Y54.59%
Perf 10Y-
Recom1.27
Target Price23.18
Prev Close19.26
Price17.70
Change %-8.10%

Analyst ratings

latest 10 of 11
DateActionAnalystRating changeTargetImplied
Sep 03, 2026InitiatedJJefferiesBuy$20+13.0%
Jan 23, 2026InitiatedMMorgan StanleyEqual-Weight$29+63.8%
Nov 25, 2025InitiatedEEvercore ISIOutperform$29+63.8%
Sep 26, 2025InitiatedJJP MorganOverweight$28+58.2%
Aug 25, 2025InitiatedNNorthland CapitalOutperform$26+46.9%
Dec 19, 2024InitiatedRRobert W. BairdOutperform$22+24.3%
Sep 26, 2024InitiatedRB. Riley SecuritiesBuy$14-20.9%
May 26, 2023ResumedCCitigroupBuy$11-37.9%
Mar 24, 2022InitiatedCCJS SecuritiesMarket Outperform$13-26.6%
Nov 29, 2021InitiatedGGoldmanBuy$14-20.9%

Peers

Mkt cap
TickerCompanyMkt cap
AMEAmetek Inc54.97B
BWXTBWX Technologies Inc11.52B
CWCurtiss-Wright Corp17.39B
OSISOSI Systems Inc3.09B
TDYTeledyne Technologies Inc29.98B
ESEEsco Technologies Inc7.42B
VREXVarex Imaging Corp780.90M
TMOThermo Fisher Scientific Inc265.92B
LDOSLeidos Holdings Inc16.33B
FTVFortive Corp20.21B

Insider trading

7 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Schopfer BrianChief Financial OfficerSep 02 '26Buy15.6020,000312,000933,290Sep 02 04:10 PM
Moore Christopher A.Chief Accounting Officer (PAO)May 07 '26Sale19.648,400164,97622,157May 08 04:08 PM
CHRISTOPHER MOOREOfficerMay 07 '26Proposed Sale19.648,400164,976May 07 04:48 PM
Kingsley Lawrence DDirectorDec 10 '25Sale24.73350,0008,654,8003,509,075Dec 12 04:05 PM
Lawrence D Kingsley RevocableDirectorDec 10 '25Proposed Sale25.00350,0008,750,000Dec 10 02:53 PM
Kingsley Lawrence DDirectorNov 21 '25Sale23.83300,0007,148,4003,900,000Nov 21 04:06 PM
Lawrence D Kingsley RevocableDirectorNov 21 '25Proposed Sale23.75300,0007,125,000Nov 21 01:30 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VGTVanguard Information Technology ETFAUM: 138.05B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
IJTiShares S&P Small-Cap 600 Growth ETFAUM: 7.45B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-270.1200.1210.030277.8275.3510
2026Q22026-07-280.1200.1030.028266.8269.329
2026Q12026-04-280.1000.095-0.014257.6244.789
2025Q42026-02-100.1500.1590.063277.4280.338
2025Q32025-10-280.1200.1000.011223.1222.127
2025Q22025-07-310.1100.1010.034222.9216.25
2025Q12025-04-290.1000.0790.001202200.715
2024Q42025-02-110.1700.1420.071254.3245.025
2024Q32024-10-290.0800.083-0.066206.8203.673
2024Q22024-08-010.1000.075-0.058207.1210.773
2024Q12024-04-300.0600.062-0.129192.6191.363
2023Q42024-02-130.1500.136-0.076230.4218.883
2023Q32023-11-010.0500.050-0.061191.2178.573
2023Q22023-08-020.0800.063-0.139197.2190.493
2023Q12023-05-030.0600.046-0.223182.1179.23
2022Q42023-02-140.1100.119-0.737217.9200.793

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-8.850-3.674-0.615322.1663.85
2022FY0.3700.380-1.529717.8703.38
2023FY0.3400.322-0.494800.9789.38
2024FY0.4100.391-0.176860.8851.52
2025FY0.4600.4870.110925.4928.43
2026FY-0.541--1,150
2027FY-0.655--1,240
2028FY-0.775--1,344

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-30980350.23346.02353.6
2026Q4S2026-10-28970348.9338353.6
2026Q4S2026-10-27811340.18335347.81
2026Q4S2026-10-12811340.18335347.81
2026Q4S2026-10-03851340.18335347.81
2026Q4S2026-09-16852340.18335347.81
2026Q4S2026-09-15852340.18335347.81
2026Q4S2026-08-25852339.7335347.81
2026Q4S2026-08-20852339.64335347.81
2026Q4S2026-08-14852339.62335347.81
2026Q4S2026-07-29851340.12335347.81
2026Q4S2026-07-20811336.35328.2348.99
2026Q4S2026-07-16810337.1328.2348.99
2026Q4S2026-07-13810337.1328.2348.99

Estimate history

EPS, annual00-0.483-0.615-1.529-0.494-0.1760.110.104
Period20182019202020212022202320242025TTM
EPS, quarterly-0.0660.0710.0010.0340.0110.063-0.0140.0280.027
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual000322.1717.8800.9860.8925.41079.6
Period20182019202020212022202320242025TTM
Sales, quarterly206.8254.3202222.9223.1277.4257.6266.8277.8
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual95.12595.12593.75208.084208.339225.965232.421250.532245.492
Period20182019202020212022202320242025MRQ
Shares, quarterly232.26232.421231.575230.43250.35250.532250.26249.026245.492
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,079.60925.40860.80800.90717.80322.100.000.000.00
Cost of Goods Sold Incl. D&A661.60572.60560.10560.60536.30241.000.000.000.00
Gross Profit418.00352.80300.70240.30181.5081.100.000.000.00
Selling, General and Administrative Excl. Other338.50286.00272.10254.10258.00142.702.450.000.00
Research and Development40.1038.9035.0031.7030.3017.00---
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income79.5066.8028.60-13.80-76.50-61.60-2.45-0.00-0.00
Interest Expense34.2042.2057.9061.9041.9059.000.00--
Unusual Expense15.2021.1010.3029.00183.7017.6043.140.000.00
Net Income Before Taxes40.1032.70-33.90-105.30-306.60-141.10-45.52-0.00-0.00
Income Taxes9.802.902.70-6.60-18.20-12.40-0.270.000.00
Consolidated Net Income30.3029.80-36.60-98.70-288.40-128.70-45.26-0.00-0.00
Net Income From Continuing Operations29.0028.80-36.10-96.90-276.90-127.90-45.26-0.00-0.00
Net Income29.0028.80-36.10-96.90-276.90-127.90-45.26-0.00-0.00
EPS (Recurring)0.150.17-0.14-0.39-0.82-0.56-0.16-0.00-0.00
EPS (Basic, Before Extraordinaries)0.120.13-0.18-0.49-1.53-0.61-0.480.000.00
EPS (Diluted)0.100.11-0.18-0.49-1.53-0.61-0.480.000.00
EBITDA232.90204.80179.00148.7097.401.30-2.45-0.00-0.00
Non-Operating Income (Expense)10.0029.205.70-0.60-4.50-2.900.070.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense17.5413.2013.3019.2030.4010.66---
Price To Earnings Ratio185.19185.19-------
Price To Sales Ratio3.576.614.162.511.676.76---
Gross Margin38.7238.1234.9330.0025.2925.18---
Operating Margin7.367.223.32-1.72-10.66-19.12---
Net Margin2.693.11-4.19-12.10-38.58-39.71---
Shares Outstanding245.49250.53232.42225.97208.34208.0893.7595.1295.12
Market Capitalization4,728.204,728.204,053.482,314.491,375.902,178.641,021.881,019.06-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue277.80266.80257.60277.40223.10222.90202.00254.30
Cost of Goods Sold Incl. D&A171.30159.40166.60164.30139.80141.20127.30154.60
Gross Profit106.50107.4091.00113.1083.3081.7074.7099.70
Selling, General and Administrative Excl. Other88.5089.0087.3073.7074.9071.4066.0070.40
Research and Development10.3010.109.6010.1010.1010.008.708.10
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income18.0018.403.7039.408.4010.308.7029.30
Interest Expense8.408.408.409.008.9011.8012.5013.20
Unusual Expense0.800.500.0013.901.006.200.000.30
Net Income Before Taxes10.9011.30-5.2023.101.207.800.6015.70
Income Taxes3.103.20-1.805.30-1.90-0.700.20-0.20
Consolidated Net Income7.808.10-3.4017.803.108.500.4015.90
Net Income From Continuing Operations7.407.70-3.4017.302.908.300.3015.00
Net Income7.407.70-3.4017.302.908.300.3015.00
EPS (Recurring)0.030.03-0.010.100.010.050.000.07
EPS (Basic, Before Extraordinaries)0.030.03-0.010.070.010.040.000.07
EPS (Diluted)0.030.03-0.010.060.010.030.000.07
EBITDA56.2057.2044.5075.0043.3044.1042.4064.00
Non-Operating Income (Expense)2.101.80-0.506.602.7015.504.40-0.10
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.615.453.403.083.482.692.693.90
Price To Earnings Ratio185.19189.94169.62198.81571.50---
Price To Sales Ratio3.574.814.646.986.595.913.784.28
Gross Margin38.3440.2535.3340.7737.3436.6536.9839.21
Operating Margin6.486.901.4414.203.774.624.3111.52
Net Margin2.662.89-1.326.241.303.720.155.90
Shares Outstanding245.49249.03250.26250.53250.35230.43231.58232.42
Market Capitalization4,728.204,491.844,657.505,944.045,442.054,993.393,370.134,053.48

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments422.00181.40134.7078.3089.500.380.010.01
Short Term Receivables276.80244.70230.40225.60216.500.000.000.00
Inventories152.60133.20144.10143.30123.600.000.000.00
Other Current Assets42.3035.4029.4033.4023.200.600.000.00
Total Current Assets893.70594.70538.60480.60452.800.980.010.01
Net Property, Plant & Equipment187.00176.60167.40164.90170.600.000.000.00
Total Investments and Advances0.100.401.101.000.70750.060.000.00
Long-Term Note Receivable21.50---0.000.00--
Intangible Assets2,478.701,837.801,986.402,068.402,469.500.000.000.00
Deferred Tax Assets98.3064.8075.1072.50-0.27--
Other Assets7.1026.5025.0023.8024.400.000.000.00
Total Assets3,686.402,700.802,793.602,811.203,118.00751.320.010.01
Short Term Debt Incl. Current Port. of LT Debt9.307.608.1014.2013.800.000.000.00
Accounts Payable57.4056.5058.7067.7059.400.000.000.00
Income Tax Payable6.607.104.205.503.200.00--
Other Current Liabilities242.80192.20194.70156.90144.6073.020.000.00
Total Current Liabilities316.10263.40265.70244.30221.0073.020.000.00
Long Term Debt1,224.40712.30712.90835.90847.700.000.000.00
Provision for Risks Charges2.903.102.302.5014.800.000.000.00
Deferred Tax Liabilities168.30125.90159.10188.80161.00---
Other Liabilities57.8037.00103.6072.5089.5026.250.000.00
Total Liabilities1,769.501,141.701,243.601,344.001,334.0099.270.000.00
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00750.000.000.00
Common Equity1,866.401,505.601,484.501,398.201,693.20-97.950.000.00
Total Shareholders Equity1,866.401,505.601,484.501,398.201,693.20652.050.000.00
Accumulated Minority Interest50.5053.5065.5069.0090.800.000.000.00
Total Equity1,916.901,559.101,550.001,467.201,784.00652.050.000.00
Total Liabilities & Stockholders Equity3,686.402,700.802,793.602,811.203,118.00751.320.010.01
Book Value Per Share7.456.486.576.718.14-1.045E-055E-05
Tangible Book Value Per Share-2.44-1.43-2.22-3.22-3.73-1.040.000.00
Full-Time Employees3,2812,8603,0002,8722,7452--
Price to Book Ratio2.652.671.570.92-10.13-10.43203.83-
Return on Assets0.90-1.31-3.46-9.34-6.61-12.05-6.82-
Return on Equity1.71-2.41-6.72-17.91-10.91-13.88-7.52-
Return on Invested Capital0.93-1.63-4.41-12.39-5.03-6.94-7.81-6.27
Quick Ratio2.341.751.481.381.490.017.8616.95
Current Ratio2.832.262.031.972.050.017.8616.95

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income30.3029.80-36.60-98.70-288.40-128.70-45.26-0.00-0.00
Depreciation153.40138.00150.40162.80174.5063.20---
Other Funds (Non Cash)39.7013.5034.6062.70228.9097.0044.210.000.00
Funds from Operations205.10159.00124.6095.9077.8011.90-1.31-0.00-0.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital7.60-15.70-26.80-0.70-38.40-11.000.360.000.00
Income Taxes Payable------0.00--
Cash from Operating Activities212.70143.3097.8095.2039.400.90-0.950.000.00
Capital Expenditures-41.60-36.40-48.80-37.10-34.20-17.600.000.000.00
Net Assets From Acquisitions-582.20-661.90-1.00-31.40-6.60-2,184.300.000.000.00
Sale of Fixed Assets and Businesses0.701.002.501.000.800.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.00-1.000.000.000.000.000.00
Other Sources0.602.703.603.800.500.000.000.000.00
Cash from Investing Activities-622.50-694.60-43.70-64.70-39.50-2,201.900.000.000.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-96.00360.10-2.00149.700.00860.40767.000.000.01
Repurchase of Common Pref Stock-96.50-49.60-2.000.000.000.000.000.000.00
Sale of Common Pref Stock0.50409.700.00149.700.00860.40767.000.000.01
Proceedsfrom Stock Options0.50409.700.00149.700.00860.40750.000.000.01
Issuance or Reduction of Debt, Net-5.20422.600.00-127.30-6.60804.200.000.000.00
Change in Long Term Debt-5.20422.600.00-127.30-6.60804.200.000.000.00
Issuance of Long Term Debt-3.80751.200.000.000.00808.300.000.000.00
Reduction of Long Term Debt-1.40-328.600.00-127.30-6.60-4.100.000.000.00
Net Financing Active Other Cash Flow-7.00-6.800.000.20-0.40-125.90-15.610.000.00
Other Financing Activities Uses-7.30-7.50-1.00-1.00-0.40-146.30-15.610.000.00
Cash from Financing Activities-108.20775.90-2.0022.60-7.001,538.70751.390.000.01
Exchange Rate Effect-4.0015.00-7.002.40-3.20-1.90---
Net Change in Cash-522.00239.6045.1055.50-10.30-664.20750.440.000.01
Free Cash Flow171.10106.9049.0058.105.20-16.70-0.950.000.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow22.5257.2173.0034.64230.27----
Deferred Taxes & Investment Tax Credit--22.30-23.80-30.90-37.20-19.60-0.270.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments419.00428.10407.70422.00940.00269.00
Short Term Receivables281.20269.10281.10276.80250.20234.70
Inventories158.70159.40157.90152.60146.00145.10
Other Current Assets46.0043.9044.2042.3050.4044.40
Total Current Assets904.90900.50890.90893.701,386.60693.20
Net Property, Plant & Equipment195.00183.80183.40187.00185.40182.90
Total Investments and Advances0.100.100.100.100.300.40
Intangible Assets2,375.602,407.202,436.402,478.701,907.001,847.90
Deferred Tax Assets---98.30--
Other Assets5.505.905.507.1016.5013.40
Total Assets3,501.103,521.003,535.903,686.403,495.802,737.80
Short Term Debt Incl. Current Port. of LT Debt7.509.209.309.308.807.10
Accounts Payable67.5060.2066.1057.4049.4045.60
Income Tax Payable4.402.304.706.602.804.10
Other Current Liabilities220.40209.90199.10242.80226.00215.60
Total Current Liabilities299.80281.60279.20316.10287.00272.40
Long Term Debt1,235.101,224.001,224.601,224.401,224.00858.00
Provision for Risks Charges2.902.902.902.903.203.20
Deferred Tax Liabilities59.3066.2068.10168.3051.8053.60
Other Liabilities68.0070.9072.6057.8037.8037.00
Total Liabilities1,665.101,645.601,647.401,769.501,603.801,224.20
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,785.901,825.801,838.301,866.401,841.301,462.30
Total Shareholders Equity1,785.901,825.801,838.301,866.401,841.301,462.30
Accumulated Minority Interest50.1049.6050.2050.5050.7051.30
Total Equity1,836.001,875.401,888.501,916.901,892.001,513.60
Total Liabilities & Stockholders Equity3,501.103,521.003,535.903,686.403,495.802,737.80
Book Value Per Share7.277.337.357.457.356.35
Tangible Book Value Per Share-2.40-2.33-2.39-2.44-0.26-1.67
Full-Time Employees---3,281--
Price to Book Ratio2.652.442.503.183.673.32
Return on Assets0.830.780.810.900.860.37
Return on Equity1.601.491.501.711.580.67
Return on Invested Capital0.240.25-0.110.560.090.36
Quick Ratio2.492.632.632.344.322.01
Current Ratio3.023.203.192.834.832.54

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income7.808.10-3.4017.803.108.50
Depreciation38.2038.8040.8035.6034.9033.80
Other Funds (Non Cash)8.8010.5011.309.106.00-3.90
Funds from Operations52.1057.2046.1049.7042.4036.20
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital7.101.30-27.2026.40-20.10-26.40
Cash from Operating Activities59.2058.5018.9076.1022.309.80
Capital Expenditures-11.90-10.40-9.50-9.80-9.30-8.80
Net Assets From Acquisitions0.00-0.200.00-582.00-79.900.00
Sale of Fixed Assets and Businesses0.000.000.000.700.300.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.300.300.800.70
Cash from Investing Activities-11.90-10.60-9.20-590.80-88.10-8.10
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-55.80-25.80-20.105.7020.70354.20
Repurchase of Common Pref Stock-55.80-25.80-20.105.200.00-34.30
Sale of Common Pref Stock0.000.000.000.5020.70388.50
Proceedsfrom Stock Options0.000.000.000.5020.70388.50
Issuance or Reduction of Debt, Net0.000.000.00-5.20717.00-289.20
Change in Long Term Debt0.000.000.00-5.20717.00-289.20
Issuance of Long Term Debt0.000.000.00-3.80755.000.00
Reduction of Long Term Debt0.000.000.00-1.40-38.00-289.20
Net Financing Active Other Cash Flow-1.300.500.20-6.40-0.200.00
Other Financing Activities Uses-0.700.000.00-6.60-0.50-0.10
Cash from Financing Activities-57.10-25.30-19.90-5.90737.5065.00
Exchange Rate Effect-0.20-1.80-4.202.20-1.1010.10
Net Change in Cash-10.0020.80-14.40-518.40670.6076.80
Free Cash Flow47.3048.109.4066.3013.001.00
Price to Free Cash Flow22.5236.0550.7160.3966.3064.93

Revenue breakdown

Cancer Care2024: 228.10M 2025: 237.00M
Labs and Research2024: 131.70M 2025: 122.20M
Nuclear2024: 316.60M 2025: 374.60M
Other Care2024: 71.60M 2025: 73.80M
Other Research2024: 112.80M 2025: 117.80M
Asia Pacific2024: 13.00M 2025: 15.60M
Europe2024: 305.60M 2025: 327.60M
North America2024: 542.20M 2025: 582.20M
Medical2024: 299.70M 2025: 310.80M
Nuclear & Safety2024: 561.10M 2025: 614.60M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3015.46%35.7M231.2M4.10M
2026-10-1517.56%41.2M234.6M4.03M
2026-09-3016.36%38.4M234.6M3.83M
2026-09-1516.93%39.7M234.6M4.08M
2026-08-3115.31%35.9M234.6M3.97M
2026-08-1413.86%32.5M234.6M4.19M
2026-07-3114.58%34.2M234.6M4.13M
2026-07-1514.69%34.7M235.9M4.08M
2026-06-3014.90%35.1M235.9M3.98M
2026-06-1512.29%29.0M235.8M3.74M
2026-05-2913.55%32.0M235.9M3.79M
2026-05-1512.80%30.2M235.9M3.63M
2026-04-3011.22%26.5M236.0M3.82M
2026-04-159.42%22.2M235.9M3.43M
2026-03-319.99%23.6M236.2M3.39M
2026-03-138.90%21.0M236.2M2.97M
2026-02-278.65%20.4M236.2M2.87M
2026-02-138.32%19.6M236.2M2.93M
2026-01-308.81%21.1M238.9M2.86M
2026-01-157.89%18.9M238.9M3.29M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5014.5017.1012.5821.1320.000.000.994-0.0180.000
call5.0012.0014.609.9011.5081.000.000.990-0.0180.001
call7.509.5012.100.008.0730.000.000.985-0.0180.001
call10.007.009.009.364.9421.000.000.964-0.0290.002
call12.504.606.506.623.5613.000.000.947-0.0260.003
call15.002.703.402.851.7052262.000.911-0.0220.004
call17.500.650.950.910.7722,1723.000.563-0.0470.011
call20.000.050.250.050.8631,00818.000.201-0.0380.008
call22.500.000.450.331.3285472.000.145-0.0470.006
call25.000.000.050.021.1089,6600.000.041-0.0160.003
call30.000.000.750.151.6887570.000.030-0.0180.002
call35.000.000.750.362.07627.000.000.026-0.0190.002
put2.500.001.850.006.2860.000.00-0.006-0.0180.000
put5.000.001.850.004.0840.000.00-0.010-0.0180.001
put7.500.001.850.152.84830.000.00-0.015-0.0170.001
put10.000.001.500.102.2555.000.00-0.036-0.0270.002
put12.500.000.200.201.4901,6800.00-0.053-0.0250.003
put15.000.050.100.080.833716204-0.089-0.0210.004
put17.500.400.700.460.733108201-0.437-0.0450.011
put20.002.152.502.300.80920422.00-0.799-0.0360.008
put22.503.705.407.901.8093.000.00-0.855-0.0450.006
put25.006.108.008.902.3620.000.00-0.960-0.0130.002
put30.0010.6013.0013.903.0490.000.00-0.970-0.0150.002
put35.0015.8018.1018.433.7220.000.00-0.974-0.0150.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-278-KCurrent report2026-10-27SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-024Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-08-318-KCurrent report2026-08-31SEC
2026-07-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-288-KCurrent report2026-07-28SEC
2026-07-028-KCurrent report2026-07-02SEC
2026-06-304Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-13SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-13SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-13SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-13SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-13SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-13SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-13SEC
2026-05-148-KCurrent report2026-05-13SEC
2026-05-084Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-07144Filing for proposed sale of securities under Rule 144.SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-04-30SCHEDULE 13GSEC
2026-04-29SCHEDULE 13GSEC
2026-04-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-288-KCurrent report2026-04-28SEC
2026-04-138-KCurrent report2026-04-09SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-09312.00K100
2026-080000
2026-070000
2026-060000
2026-0500164.98K1
2026-040000
2026-030000
2026-020000
2026-010000
2025-12008.65M1
2025-110011.48M4

Institutional holders

Manager% owned
BlackRock, Inc.15.27%
VANGUARD PORTFOLIO MANAGEMENT LLC7.26%
T. Rowe Price Investment Management, Inc.5.70%
VANGUARD CAPITAL MANAGEMENT LLC4.24%
GOLDMAN SACHS GROUP INC4.15%
STATE STREET CORP3.96%
Alyeska Investment Group, L.P.3.81%
COOPERMAN LEON G3.35%
GEODE CAPITAL MANAGEMENT, LLC2.44%
CONGRESS ASSET MANAGEMENT CO2.42%

Funds

Fund% owned
Franklin Convertible Securities Fund10.84%
NYLIM MacKay Convertible Fund7.61%
iShares Core S&P Small-Cap ETF5.88%
CALAMOS STRATEGIC TOTAL RETURN FUND4.52%
NYLIM VP MacKay Convertible Portfolio3.73%
Calamos Growth & Income Fund3.54%
iShares Convertible Bond ETF3.31%
CALAMOS CONVERTIBLE & HIGH INCOME FUND3.21%
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND3.01%
Calamos Market Neutral Income Fund3.01%

OakChart. MIR. Cached 15 minutes.